BioTuesdays

Category - Executive Moves

Executive Moves

Laurie Keating joins Kalaris BOD

Kalaris Therapeutics (NASDAQ: KLRS) has announced the appointment of Laurie Keating to its board of directors (BOD), effective August 1, 2026, and the departure of Morana Jovan-Embiricos from the board. Ms. Keating...

July 7, 2026
Executive Moves

Longeveron appoints Marie Washburn as CFO

Longeveron (NASDAQ: LGVN) has announced the appointment of Marie Washburn as senior vice president and chief financial officer (CFO), effective July 13, 2026. Ms. Washburn has served as Longeveron’s vice president...

July 7, 2026
Executive Moves

Inogen appoints Andy Reding as COO

Inogen (NASDAQ: INGN) has announced the appointment of Andy Reding to the newly created role of chief operating officer (COO), effective Monday, July 6, 2026. Mr. Reding will be responsible for driving revenue and...

July 2, 2026
Executive Moves

Dr. Iain Dukes joins Dogwood as chair of SAB

Dogwood Therapeutics (NASDAQ: DWTX) has announced the appointment of Iain Dukes, PhD, as chair of the company’s scientific advisory board (SAB). Dr. Dukes is a veteran biopharma industry executive and partner with...

June 30, 2026
Candel Therapeutics Logo
Executive Moves

Candel appoints Mark Sims as CCO

Candel Therapeutics (NASDAQ: CADL) has announced the appointment of Mark Sims as its chief commercial officer (CCO), effective July 6, 2026. Mr. Sims will lead Candel’s commercial strategy and launch readiness for...

June 25, 2026
4basebio Logo
Executive Moves

Dr. Jeff Coller joins 4basebio’s SAB

4basebio (AIM: 4BB) has appointed Jeff Coller, PhD, to its strategic advisory board (SAB). Dr. Coller is a globally recognized expert in mRNA biology and translation. According to 4basebio, his understanding of...

June 15, 2026
Cocrystal Pharma Logo
Executive Moves

Cocrystal appoints James Sapirstein as CEO

Cocrystal Pharma (NASDAQ: COCP) has appointed biopharma industry leader James Sapirstein as chief executive officer (CEO), effective immediately. According to Cocrystal, Mr. Sapirstein will also be appointed to its...

June 4, 2026
Defence Therapeutics Logo
Executive Moves

Dr. John Lambert joins Defence BoD

Defence Therapeutics (CSE: DTC; OTCQB: DTCFF; FSE: DTC) has appointed Dr. John Lambert to its board of directors (BoD), effective immediately. Internationally recognized, Dr. Lambert brings more than four decades of...

June 1, 2026